| Year |
Citation |
Score |
| 2013 |
Hahn T, Polanczyk MJ, Borodovsky A, Ramanathapuram LV, Akporiaye ET, Ralph SJ. Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors. Current Pharmaceutical Biotechnology. 14: 357-76. PMID 22201597 DOI: 10.2174/1389201011314030010 |
0.648 |
|
| 2012 |
Basu-Roy U, Seo E, Ramanathapuram L, Rapp TB, Perry JA, Orkin SH, Mansukhani A, Basilico C. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene. 31: 2270-82. PMID 21927024 DOI: 10.1038/Onc.2011.405 |
0.362 |
|
| 2009 |
Rausch MP, Hahn T, Ramanathapuram L, Bradley-Dunlop D, Mahadevan D, Mercado-Pimentel ME, Runyan RB, Besselsen DG, Zhang X, Cheung HK, Lee WC, Ling LE, Akporiaye ET. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer. Anticancer Research. 29: 2099-109. PMID 19528470 |
0.735 |
|
| 2007 |
Neuzil J, Dong LF, Ramanathapuram L, Hahn T, Chladova M, Wang XF, Zobalova R, Prochazka L, Gold M, Freeman R, Turanek J, Akporiaye ET, Dyason JC, Ralph SJ. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Molecular Aspects of Medicine. 28: 607-45. PMID 17499351 DOI: 10.1016/J.Mam.2007.02.003 |
0.612 |
|
| 2006 |
Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Research. 66: 9374-8. PMID 17018590 DOI: 10.1158/0008-5472.Can-06-2403 |
0.677 |
|
| 2006 |
Hahn T, Alvarez I, Kobie JJ, Ramanathapuram L, Dial S, Fulton A, Besselsen D, Walker E, Akporiaye ET. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer. International Journal of Cancer. Journal International Du Cancer. 118: 2220-31. PMID 16331615 DOI: 10.1002/Ijc.21616 |
0.773 |
|
| 2006 |
Ramanathapuram LV, Hahn T, Graner MW, Katsanis E, Akporiaye ET. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines. Cancer Immunology, Immunotherapy : Cii. 55: 166-77. PMID 16041582 DOI: 10.1007/S00262-005-0016-7 |
0.728 |
|
| 2005 |
Ramanathapuram LV, Hahn T, Dial SM, Akporiaye ET. Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination. Nutrition and Cancer. 53: 177-93. PMID 16573379 DOI: 10.1207/S15327914Nc5302_7 |
0.765 |
|
| 2004 |
Ramanathapuram LV, Kobie JJ, Bearss D, Payne CM, Trevor KT, Akporiaye ET. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells. Cancer Immunology, Immunotherapy : Cii. 53: 580-8. PMID 14991239 DOI: 10.1007/S00262-004-0499-7 |
0.764 |
|
| 2004 |
Hahn T, Alvarez I, Ramanathapuram L, Dial S, Akporiaye E. Dietary Celecoxib Enhances the Efficacy of Tumor Lysate-Pulsed Dendritic Cell Vaccines in Treating Murine Breast Cancer Journal of Immunotherapy. 27: S22-S23. DOI: 10.1097/00002371-200411000-00083 |
0.729 |
|
| 2003 |
Kobie JJ, Wu RS, Kurt RA, Lou S, Adelman MK, Whitesell LJ, Ramanathapuram LV, Arteaga CL, Akporiaye ET. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Research. 63: 1860-4. PMID 12702574 |
0.682 |
|
| Show low-probability matches. |